In yesterday’s Wall Street session, Nano-X Imaging Ltd. (NASDAQ:NNOX) shares traded at $6.80, down -15.21% from the previous session.
As of this writing, 2 analysts cover Nano-X Imaging Ltd. (NASDAQ:NNOX). The consensus rating among analysts is ‘Overweight’. NNOX stock price is now -39.59% away from the 50-day moving average and -40.36% away from the 200-day moving average. The market capitalization of the company currently stands at $369.99M.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
There are 1 analysts who have given it a hold rating, whereas 1 have given it a buy rating.
With the price target of $52, Ladenburg Thalmann recently initiated with Buy rating for Nano-X Imaging Ltd. (NASDAQ: NNOX)., while ‘Cantor Fitzgerald’ rates the stock as ‘Overweight’.
A total of 15.26% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in NNOX stock. A new stake in Nano-X Imaging Ltd. shares was purchased by D. E. SHAW & CO., INC. during the first quarter worth $566,000. BNP PARIBAS ARBITRAGE, SNC invested $128,000 in shares of NNOX during the first quarter. In the first quarter, PARAMETRIC PORTFOLIO ASSOCIATES LLC acquired a new stake in Nano-X Imaging Ltd. valued at approximately $110,000. ALLIANCEBERNSTEIN L.P. acquired a new stake in NNOX for approximately $92,000. STATE OF WISCONSIN INVESTMENT BOARD purchased a new stake in NNOX valued at around $71,000 in the second quarter. In total, there are 135 active investors with 17.70% ownership of the company’s stock.
Tuesday morning saw Nano-X Imaging Ltd. (NASDAQ: NNOX) opened at $7.97. During the past 12 months, Nano-X Imaging Ltd. has had a low of $7.99 and a high of $17.50. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 2.10, and a quick ratio of 2.10. The fifty day moving average price for NNOX is $11.26 and a two-hundred day moving average price translates $11.40 for the stock.
The latest earnings results from Nano-X Imaging Ltd. (NASDAQ: NNOX) was released for Jun, 2022. According to the Medical Devices Company, earnings per share came in at -$0.38, missing analysts’ expectations of -$0.25 by -0.13. This compares to -$0.28 EPS in the same period last year. For the current quarter, analysts expect NNOX to generate $2.81M in revenue.
Nano-X Imaging Ltd.(NNOX) Company Profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
